B · Normal
[The concept of innovative drugs fluctuated and weakened, and Bepsis fell by more than 10%] On September 10, the concept of innovative drugs fluctuated and weakened in early trading, with CRO leading the decline. Bepsis fell by more than 10%, and Nearshore Protein, Wanbang Pharmaceuticals, Yiqiao Shenzhou, Boji Pharmaceuticals, Baihua Pharmaceuticals, and Hongbo Pharmaceuticals all fell by more than 5%.
Live broadcast 🕐 2026-09-10 09:49
#Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Analysis of listed stocks on September 22: The promotion rate of listed stocks 09-22 16:11 [Analysis of daily limit on September 22] On September 22, a total of 62 stocks 09-22 15:21 [Review: The GEM index rose slightly after rising, and AI application concept st 09-22 15:02 [The turnover of the Shanghai and Shenzhen stock markets exceeded 2 trillion, an 09-22 14:47 [The three major indexes all turned green] On September 22, the indexes rose and 09-22 14:32 [Main Fund Monitoring: The net outflow of the communications sector exceeds 3.6 09-22 14:20

Comments

0/500
Captcha (click to refresh)
No comments yet